World of DTC Marketing
JUNE 22, 2022
Advanced economies typically spend about 10% of GDP on keeping their citizens in good health, a share that is rising as populations age. America’s profit-riddled healthcare-industrial complex consumes 17% of GDP, equivalent to $3.6trn a year. That is unsustainable. However, changes are slowly being implemented that could lower healthcare costs.
MedCity News
JUNE 22, 2022
The speed of Covid-19 vaccine trials should inspire the pharmaceutical and medical device industries to accelerate its clinical testing, according to Shweta Maniar, Google Cloud’s director for healthcare and life sciences. She argued that harnessing real-world data will make faster clinical trials achievable for all therapeutics and devices, possibly even eliminating the need to recruit a placebo arm.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JUNE 22, 2022
The pandemic highlighted how fragile the global manufacturing network is, as supply of certain products was limited and regulatory inspections became difficult to carry out. Ben Hargreaves finds out how the issue of foreign manufacturing has become a major US political talking point and how this could influence the pressures facing the industry. In a global economy, across a number of industries, low-margin products are often manufactured in countries where labour is cheap.
Medgadget
JUNE 22, 2022
Engineers at the University of California Los Angeles have developed “meta-bots,” which are fingernail sized robots that can move, sense, and navigate their environment. Strikingly, the robots are essentially ready for use when they emerge from the 3D printer, and consist of piezoelectric actuators that can respond to or generate electricity. The robots consist of an intricate structure of piezoelectric components that allow them to rapidly flex and rotate.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
JUNE 22, 2022
Pfizer has harnessed the expertise of health data specialist Truveta to provide close monitoring of safety and other signals for its products, including COVID-19 vaccine Comirnaty, almost in real-time. Truveta’s platform is based on electronic medical record data – updated daily – for more than 50 million people in the US, harvesting anonymised patient care information from tens of thousands of clinical care sites across 42 states.
MedCity News
JUNE 22, 2022
The Clarifying Remanufacturing to Protect Patient Safety Act was introduced by Reps. Scott Peters (D-CA), Kim Schrier (D-WA), and John Joyce (R- PA) to clarify the meaning of medical device remanufacturing and empower the FDA to educate company technicians so they know if they’ve crossed the line into a regulated activity. .
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
JUNE 22, 2022
Novartis is paying Precision Bio $75 million up front to begin a partnership aiming to develop in vivo gene-editing therapies for serious genetic blood disorders, such as sickle cell disease. One of the goals of the alliance is to make genetic medicines more globally accessible.
Medgadget
JUNE 22, 2022
Researchers at the Chalmers University of Technology in Sweden have developed a “polymer brush” system that can capture and release proteins on using electrical stimulation. Protein therapeutics are increasingly in demand, but creating them efficiently is still a challenge. Isolating therapeutic proteins from the liquid surrounding the cells used to produce them in biotechnological processes is difficult and inefficient, but the researchers behind this latest technology hope that the new techniq
MedCity News
JUNE 22, 2022
Providence spun out Advata two weeks ago, and the startup, which has 30 customers and 150 employees, sells a suite of insights-focused data software products designed to improve population health and revenue cycle management.
PharmaTimes
JUNE 22, 2022
Novartis receives approval from the European Commission for Tabrecta for the treatment of non-small cell lung cancer
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
JUNE 22, 2022
A veteran of GE Healthcare, Joe Gasque talks about how he's growing the company's niche position in the high-paced aesthetics industry, offering services to surgeons, practitioners, medical device and injectables manufacturers.
Pharmaceutical Technology
JUNE 22, 2022
BioMarin Pharmaceutical has obtained Japan’s Ministry of Health, Labor and Welfare (MHLW) approval of the registration for its Voxzogo (vosoritide) for injection to treat achondroplasia in children whose growth plates are not closed. A modified C-type natriuretic peptide (CNP), Voxzogo acts on achondroplasia’s underlying pathophysiology. It works by down-regulating fibroblast growth factor receptor 3 (FGFR3) signalling and subsequently boosting endochondral bone formation.
MedCity News
JUNE 22, 2022
The ability of healthcare providers to leverage accurate, sophisticated and timely diagnostic testing for infertility patients is a crucial part of the patient journey.
Copyright Clearance Center
JUNE 22, 2022
The post Part 2: Workflow of the Future: Copyright & Standards appeared first on Copyright Clearance Center.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
MedCity News
JUNE 22, 2022
An Alzheimer’s disease drug from Athira Pharma has failed a Phase 2 clinical trial and the biotech has a surprising theory why. Athira says standard of care drugs Alzheimer’s patients are already taking may diminish the effect of its small molecule and this finding could inform how the company proceeds with an ongoing Phase 3 clinical trial.
Pharmacy Times
JUNE 22, 2022
Even if the financial resources were available, there aren’t enough human resources in pharmacy to provide high-touch engagement to the millions of patients who suffer from common chronic diseases.
MedCity News
JUNE 22, 2022
Collecting SDOH, adding this data to patient profiles, enabling health data analytics, and taking data-based actions has proven to help significantly.
PharmaTimes
JUNE 22, 2022
The MS Society responds as MS therapy Fampyra is rejected
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Scott’s Directories
JUNE 22, 2022
A lot of the time, when sales representatives choose to cold call, the chances of success can increase or decrease simply based on the timing of their call. Predicting when to call is tough. Taking into account a doctor’s busy schedule makes it even harder to predict just the right time to call. Luckily, enough research has been done on the best times to call.
Curzon Consulting
JUNE 22, 2022
The issue •With a re-focusing of the organization on energy transition and a strategic objective to grow B2C Mobility and Convenience revenue streams, the current, largely B2B, customer care service model was increasingly being asked to meet needs beyond core capabilities and capacity, putting a strain on service and cost to serve. •With limitations on internal capability, business units have chosen to outsource services, leading to a proliferation of suppliers, models and customer experiences.
Impetus Digital
JUNE 22, 2022
Register for Impetus’ upcoming live webinar on July 5, 10-11 AM ET: A Fireside Chat with Dr. Bassil Akra, CEO of Akra Team GmbH. About the webinar. Dr. Bassil Akra , CEO of AKRA TEAM GmbH , will join Natalie Yeadon for a deep dive into the new approval process for medical devices in the EU. Among many other things, he will share his insights into how Medical Device and In Vitro Diagnostic companies can get safe, qualitative, and well-performing products onto the EU market with minimal delays.
PharmaTech
JUNE 22, 2022
Thursday, June 23, 2022 at 10am ET | 3pm BST | 4pm CEST Join us on June 23 to learn about QC Analysis of Oligonucleotide Therapeutics. One Platform Method for Determining Identity, Purity, and Quantity.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
pharmaphorum
JUNE 22, 2022
Six in 10 respondents to Health Union’s Spondyloarthritis In America 2021 survey said they feel other people in their lives don’t understand the risks of being immunocompromised. And they aren’t alone. Scientists estimate nearly 3% of people in the U.S. can be considered immunocompromised, meaning their immune system and their ability to fight infections and other diseases is weakened.
PharmExec
JUNE 22, 2022
Mr. Horvath, who brings over a decade of experience in pharmaceutical commercialization, will lead the commercialization of POINT’s pipeline.
Pharmacy Times
JUNE 22, 2022
Vaxneuvance is now indicated for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals 6 weeks of age and older.
Pharmaceutical Commerce
JUNE 22, 2022
Maria Kirsch points to three key objectives in building effective patient support programs.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Pharmacy Times
JUNE 22, 2022
Jardiance shows reduction of 50% compared with dipeptidyl peptidase-4 inhibitors and 30% compared with glucagon-like peptide 1 receptor agonists.
PharmExec
JUNE 22, 2022
Agency leaders seek to build public trust in science and gain support for regulation.
Pharmacy Times
JUNE 22, 2022
Kai Zhao, PhD, director of the Nasal Physiology and Therapeutic Center in the Department of Otolaryngology at Ohio State University College of Medicine, discusses how patients who have experienced a loss of taste and smell following COVID-19 infection may be impacted by this symptom for years without realizing it.
Penrod
JUNE 22, 2022
The post The Guide to Salesforce Org Migrations appeared first on Penrod.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
227 
Let's personalize your content